Palliative Performance Scale
Palliative Performance Scale (PPS) · Also known as: PPS
The Palliative Performance Scale (PPS) is an 11-point clinician-rated functional assessment tool for patients with advanced, life-limiting illness. Developed by Anderson and colleagues in 1996, it measures overall performance status from 100% (normal) to 0% (death), integrating five domains of functional decline. The PPS is widely used in palliative care, hospice, and oncology settings to guide treatment intensity, prognostication, and care planning.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The PPS is indicated in all advanced cancer patients, patients with progressive non-malignant disease (e.g., COPD, heart failure, dementia), and any population with life expectancy <6 months. It is especially valuable at initial palliative care consultation, in care planning meetings with families, for prognostication, and to guide shifts from curative to comfort-focused approaches. Use it serially (e.g., weekly) to monitor decline and anticipate caregiver needs. The PPS is less useful for early-stage cancer or patients with stable chronic disease expecting prolonged survival.
Strengths & limitations
- Rapid clinician-rated assessment requiring minimal training, reducing administrative burden in busy palliative teams.
- Strong prognostic value: PPS correlates directly with survival, with median survival <8 weeks at PPS 40% and <2 weeks at PPS 10%; aids honest prognostication conversations.
- Integrates five clinically salient domains (ambulation, activity, self-care, intake, consciousness) into one interpretable score that aligns with family and patient intuitions.
- Explicitly links to hospice enrollment criteria in many jurisdictions; score ≤50% often meets palliative/hospice thresholds.
- Widely adopted internationally (Canada, Australia, Europe, USA) with strong published validation in diverse palliative populations including cancer, organ failure, and dementia.
- Ordinal scale (not interval) limits statistical power; 10-point increments may miss clinically meaningful changes between categories.
- Clinician subjectivity: Definitions of 'some disease evidence' or 'adequate intake' are somewhat vague; inter-rater reliability varies (reported 0.80–0.90) and requires clinical experience.
- No patient self-report component; relies entirely on observation, potentially masking patient-reported quality of life or psychological distress.
- Weak in differentiating causes of functional decline (e.g., pain vs. depression vs. delirium); does not replace detailed symptom assessment.
- Modest predictive precision for individual prognostication; median survival estimates are population-level and highly variable; should not be used as sole basis for time-critical decisions.
Frequently asked
How do I decide between 60% and 70% if the patient is borderline?
The key distinction is bed rest burden: 70% patients spend >50% of time in bed but retain substantial independence; 60% patients require assistance with most activities of daily living and spend most waking hours in bed. Observe over 3–5 days; if assistance is needed for toileting, dressing, or self-care, assign 60% or lower.
Can PPS improve or remain stable for extended periods?
Yes. PPS may improve transiently (e.g., from 40% to 50%) with treatment of reversible conditions (infection, dehydration, pain control). Some patients stabilize at a given level for weeks to months (e.g., dementia patients at 40–50% for years). Reassess when clinical status changes, not on a fixed schedule, unless tracking for research.
Is PPS validated in non-cancer populations?
Yes. PPS has been validated in organ failure (heart failure, COPD, renal disease), dementia, AIDS, and neurological disease. However, survival estimates may differ by disease: organ failure patients at 40% PPS may have longer median survival (8–12 weeks) than cancer patients (4–8 weeks). Consult disease-specific prognostic data for accuracy.
Who administers the PPS—nurse, physician, or care team?
Physicians or experienced nurses familiar with the patient administer it. In multidisciplinary teams, consensus scoring (brief discussion if raters disagree by >10%) improves reliability. Training is brief (watch exemplar cases, review definitions); formal certification is not required but recommended for new teams.
Sources
- Anderson, F., Downing, G. M., Hill, J., Casorso, L., & Lerch, N. (1996). Palliative Performance Scale: A new tool. J Palliat Care, 12(1), 5–11. DOI: 10.1177/082585979601200102 ↗
- Glare, P. A., Semple, D., & Staquet, M. J. (2011). Palliative Performance Scale. In A. G. Liptak (Ed.), Palliative care: Core skills and clinical competencies (2nd ed., pp. 421–428). Saunders. link ↗
How to cite this page
ScholarGate. (2026, June 3). Palliative Performance Scale (PPS). ScholarGate. https://scholargate.app/en/palliative-care/palliative-performance-scale
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Comfort Care ChecklistPalliative Care↔ compare
- FACIT-Palliative SubscalePalliative Care↔ compare
- McGill Quality of Life QuestionnairePalliative Care↔ compare
- Patient Dignity InventoryPalliative Care↔ compare
- Spiritual Well-Being ScalePalliative Care↔ compare